Treatment

[Ac-225]-PSMA-62 (mCRPC) clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
This study is testing a new treatment, [Ac-225]-PSMA-62, for advanced prostate cancer. It aims to find the safest and most effective dose, and see how well it works in men whose cancer has spread or returned.
For: Prostate Cancer · Metastatic Castration-resistant Prostate Cancer · Oligometastatic Prostate Carcinoma
Canada